Our data showed that Vimentin expression is considerably associated with the onset age (P = 0.007), lymph node metastasis (P = 0.007), lymphatic invasion (P = 0.024), disease recurrence (P < 0.001), and the clinical prognosis of patients (P < 0.001) (Table 2). This evidence concerns the gene VIM and metastatic malignant neoplasm in the lymph nodes.